The CSP team has more than 150 years of experience on Wall Street. 
We have worn every hat from stock broker, to banker to the CEO of Public Companies. We know what investors should invest in in new growth industries such as The Cannabis Sector.
 
 
 

 

The CSP team has more than 150 years of experience on Wall Street...

 

Cannabis Stock Picks will FOCUS on the key investments at the three levels...

 

We will cover the People, Places and Products the law allows and keep you posted...

  • 22nd Century Group, Inc. (NYSE: XXII)

    Breaking News: FDA wants to make cigarettes less addictive by slashing nicotine in them. For the first time, the federal government is proposing cutting the nicotine level in cigarettes so they aren’t so addictive. U.S. Food and Drug Administration chief Scott Gottlieb directed the agency’s staff Friday to develop new regulations on nicotine. The FDA has had the power since 2009 to regulate nicotine levels, but so far it hasn’t done so. In response to the news, Altira Group, British American Tobacco, Imperial Brands and Vector Group lost a cumulative $21 billion in market value. Who wins? 22nd Century, whose technology Click here to Read More

  • Pot comes to Sin City: Recreational use is now law in Nevada as weed makes for strange bedfellows

    Public support for legal marijuana has hit record highs, and at least one close advisor to President Trump is pushing for full legalization. The weed economy is booming, even as the federal government takes a hard line against pot. Legal pot is also being touted as a weapon in the opioid epidemic. The movement to legalize marijuana notched a new victory with Nevada becoming the latest state to make recreational weed legal as of Saturday. At least half of U.S. states have legalized pot for either recreational or medical purposes. With polls showing record high support for legal marijuana among Click here to Read More

  • Q&A with CEO of CannaRoyalty (CNNRF), (CSE:CRZ), Marc Lustig

    CannaRoyalty is a fully integrated, active investor and operator in the legal cannabis sector. Our focus is building and supporting a diversified portfolio of growth-ready assets in high-value segments of the cannabis sector, including research, consumer brands, devices and intellectual property. Our management team combines a hands-on understanding of the cannabis industry with seasoned financial know-how, assembling a platform of holdings via royalty agreements, equity interests, secured convertible debt, licensing agreements and its own branded portfolio. Mr. Lustig holds MSc and MBA degrees from McGill University. He began his professional career in the pharmaceutical industry at Merck & Co. In Click here to Read More

  • CannaRoyalty Corp. (OTC: CNNRF)

    By Gary Anderson – CannaRoyalty Corp. (CNNRF): Unique Business Model a Big Winner in Cannabis Space CannaRoyalty Corp. (CNNRF) and (CSE:CRZ), has a unique business model in the cannabis space that minimizes risk and maximizes reward CannaRoyalty holds 22 strategic, diverse cannabis assets throughout North America Just one $850,000 investment in one cannabis asset now valued at $7.1M Exceptionally strong management team and board of directors positioning company to capitalize on high-growth cannabis market This article will provide an overview of CannaRoyalty’s intriguing business model and distinguished management team, and identify the company’s diversified cannabis assets. A future article will take Click here to Read More

  • 22ND CENTURY GROUP, INC. (NYSEMKT: XXII)

    Company Overview: 22nd Century is a plant biotechnology company focused on technology, which allows the company to increase or decrease the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants through genetic engineering and plant breeding. The company’s primary mission in tobacco is to reduce the harm caused by smoking. The company’s primary mission in cannabis is to develop proprietary cannabis strains for important new medicines and agricultural crops. 22nd Century currently owns or exclusively controls more than 200 issued patents and more than 50 pending patent applications around the world. Investment Thesis: The key Click here to Read More

For non-members – our team welcomes you to try CannabisStockPicks